BioPortfolio - Biovail - Profile
Biovail Patents:. • 7241805- Modified release formulations of a bupropion salt. • 6967218- Pravastatin pharmaceutical formulations and methods of their use ...
http://www.bioportfolio.com/biocorporate/1994-Biovail.pdf...
|
News: Izard Nobel LLP Announces Class Action Lawsuit against ...
... a salt formulation of bupropion, an antidepressant commonly known as ... before the market opened, Biovail issued a press release announcing that it had
...
http://www.genengnews.com/news/bnitem.aspx?name=43271270...
|
BioPortfolio - Biovail
US Patent No. Title. 7241805, Modified release formulations of a bupropion salt. 6967218, Pravastatin pharmaceutical formulations and methods of their use ...
http://www.bioportfolio.com/biocorporate/1994-Biovail.html...
|
JAMES M. FERGUSON, M.D.
Multicenter Study of XXXXXX One a Day Formulation with a 16 Month Open-Label ... A Double-Blind, Placebo-Controlled Study of Modified Release XXXXXX in ...
http://www.radiantresearch.com/investigators/Ferguson,%20MD....
|
BioPortfolio - Collodion - InDepth
7241805- Modified release formulations of a bupropion salt. • 7253418- Device and method for the examination of samples in a non vacuum environment using a
...
http://www.bioportfolio.com/indepth/Collodion.pdf...
|
Clinical Pharmacology & Therapeutics - Table of Contents
Pharmacokinetic profile of a new modified-release formulation of zolpidem ...... Plasma levels of bupropion (BUP), major metabolites and antidepressant ...
http://www.nature.com/clpt/journal/v77/n2/index.html...
|
Treatment of adults with attention-deficit/hyperactivity disorder
An open trial of bupropion for the treatment of adult patients with ADHD and comorbid bipolar disorder suggested that sustained-release bupropion may be ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=25...
|
...
|
Patent alert
method, and bupropion, which is one of five second α3β4 .... amyloid β and the use of a sustained-release formulation of. a HMG-CoA reductase inhibitor is ...
http://www.biomedcentral.com/content/pdf/cd-468431.pdf...
|
Financial Report Cover
a controlled-release formulation of bupropion (Wellbutrin), in ...... different salt form of paroxetine than that used in the marketed. form of Paxil. ...
http://www.gsk.com/investors/reports/reps01/annual-report-20...
|
